Literature DB >> 1426162

Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents.

L Salleras1, M Bruguera, J Vidal, J L Taberner, P Plans, J M Bayas, T Pumarola, M T Jimenez de Anta, J Rodés.   

Abstract

The prevalence of hepatitis B markers was determined in a representative sample of the general population of Catalonia (Spain). HBsAg was found in 0.5% of children (less than 15 years of age) and in 1.7% of adults (more than 15 years of age), and anti HBs in 1.6% and 18%, respectively. Age-specific prevalence for both markers showed a low risk for hepatitis B before puberty, and a progressive rise since adolescence, suggesting that perinatal transmission and horizontal transmission in children are relatively uncommon in Spain. Prevalence of hepatitis B markers was significantly higher among subjects with low education level, residing in an urban area and born outside Catalonia, but in the stratified analysis, a statistical significant difference was only maintained in the prevalence of HBV markers between those who live in urban and rural areas, and between those who were born outside Catalonia and in Catalonia. These data may be used as a basis for a strategy of hepatitis B prevention in Spain which include universal vaccination of adolescents, passive-active immunization of newborns to HBsAg positive mothers and vaccination of susceptible adults subjects from high-risk groups.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426162     DOI: 10.1007/bf00145377

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  12 in total

1.  Vertical transmission of hepatitis B antigen in Taiwan.

Authors:  C E Stevens; R P Beasley; J Tsui; W C Lee
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

2.  Seroepidemiological survey of hepatitis B infection in a cohort of military recruits in Barcelona, Spain.

Authors:  J L Taberner; M Bruguera; M C Rodriguez; A Mayor; J Batalla
Journal:  Eur J Epidemiol       Date:  1992-01       Impact factor: 8.082

3.  [High risk of hepatitis B virus infection in the gypsy population].

Authors:  E Fos; A Diéguez; F R Hierro; M Cruz; M Bruguera
Journal:  Med Clin (Barc)       Date:  1987-10-24       Impact factor: 1.725

4.  Prevalence of hepatitis B markers in Italy.

Authors:  P Pasquini; H A Kahn; D Pileggi; A Panà; J Terzi; E Guzzanti
Journal:  Am J Epidemiol       Date:  1983-11       Impact factor: 4.897

5.  Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis.

Authors:  M J Alter; P J Coleman; W J Alexander; E Kramer; J K Miller; E Mandel; S C Hadler; H S Margolis
Journal:  JAMA       Date:  1989-09-01       Impact factor: 56.272

6.  Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980.

Authors:  G M McQuillan; T R Townsend; H A Fields; M Carroll; M Leahy; B F Polk
Journal:  Am J Med       Date:  1989-09-04       Impact factor: 4.965

7.  Hepatitis B infection in the United States. Recent trends and future strategies for control.

Authors:  M A Kane; M J Alter; S C Hadler; H S Margolis
Journal:  Am J Med       Date:  1989-09-04       Impact factor: 4.965

8.  Hepatitis B virus infection in children in Sardinia, Italy.

Authors:  T Stroffolini; E Franco; G Romano; P Uccheddu; P Pasquini; A Panà; A Maida; B Scarpa
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

9.  The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.

Authors:  M J Alter; S C Hadler; H S Margolis; W J Alexander; P Y Hu; F N Judson; A Mares; J K Miller; L A Moyer
Journal:  JAMA       Date:  1990-03-02       Impact factor: 56.272

10.  Hepatitis B virus transmission between heterosexuals.

Authors:  M J Alter; J Ahtone; I Weisfuse; K Starko; T D Vacalis; J E Maynard
Journal:  JAMA       Date:  1986-09-12       Impact factor: 56.272

View more
  4 in total

1.  Cost-effectiveness analysis of hepatitis B vaccination strategies in Catalonia, Spain.

Authors:  F Antoñanzas; R Garuz; J Rovira; F Antón; C Trinxet; E Navas; L Salleras
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

2.  Prevalence of hepatitis B infection in long-stay mentally handicapped adults.

Authors:  F Asensio; J M Bayas; M J Bertran; M A Asenjo
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

3.  Cost effectiveness of hepatitis A virus immunisation in Spain.

Authors:  J M Arnal; O Frisas; R Garuz; F Antoñanzas
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

4.  The impact of immigration and vaccination in reducing the incidence of hepatitis B in Catalonia (Spain).

Authors:  Manuel Oviedo; M Pilar Muñoz; Gloria Carmona; Eva Borrás; Joan Batalla; Nuria Soldevila; Angela Domínguez
Journal:  BMC Public Health       Date:  2012-08-06       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.